Filing Flows › Picard Medical (PMI) › Q2 2026 › vs Q1 2026
Picard Medical (PMI) Q2 2026 vs Q1 2026 (quarter over quarter)
Picard Medical's revenue rose $1.8M (+157%) from $1.1M in Q1 2026 to $3.0M in Q2 2026. The biggest changes: Product +$2.0M (+211%); Rentals −$188K (-91%).
Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%, net loss $5.7M, operating cash flow −$1.4M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $2.9M | $943K | $2.0M | +211% |
| Rentals | $19K | $207K | −$188K | -91% |
| Revenue | $3.0M | $1.1M | $1.8M | +157% |
| Net loss | $5.7M | $7.6M | −$2.0M | -26% |
| Costs & expenses | $8.6M | $8.8M | −$152K | -2% |
| Operating costs | $7.6M | $5.7M | $1.9M | +34% |
| Interest & other, net | $1.0M | $3.1M | −$2.1M | -67% |
| Income tax | $7K | $0 | $7K | — |
| Cost of revenue | $2.3M | $875K | $1.5M | +167% |
| Research & development | $1.4M | $1.9M | −$521K | -27% |
| SG&A | $3.9M | $2.9M | $980K | +34% |
| Operating cash sources | $5.7M | $7.6M | −$2.0M | -26% |
| Depreciation & amortization | $45K | $46K | −$1K | -2% |
| Share-based compensation | $1.4M | $165K | $1.2M | +736% |
| Working capital & other | $2.9M | $3.6M | −$722K | -20% |
| Cash used in operations | $1.4M | $3.8M | −$2.4M | -64% |
| Net loss absorbed | $5.7M | $7.6M | −$2.0M | -26% |
Questions
How much did Picard Medical's revenue grow quarter over quarter in Q2 2026?
Picard Medical's revenue rose $1.8M (+157%) from $1.1M in Q1 2026 to $3.0M in Q2 2026.
What drove Picard Medical's revenue change in Q2 2026?
Product +$2.0M (+211%); Rentals −$188K (-91%).